Molecular Partners is a biotechnology company developing and selling high-quality binding molecules for applications in life sciences and healthcare. Molecular Partners’ binding molecules are based on designed repeat proteins (DRPs). These equal antibodies – used to date in target binding – in terms of affinity and specificity, but surpass them in terms of stability and production yields. As DRPs can be generated at unparalleled speed, without the need for animals, and at an extraordinarily high success rate, they result in lower costs. Molecular Partners seeks to offer its molecules on the biotechnological, diagnostic and therapeutic applications markets. The DRP technology has been covered by an “umbrella patent”, for which the company has an exclusive license.